Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China Department of Endocrinology, Peking University First Hospital, Beijing, China OUTCOMES RESEARCH Consortium, Cleveland, OH, USA.
Int J Surg. 2022 Feb;98:106215. doi: 10.1016/j.ijsu.2021.106215. Epub 2022 Jan 4.
Preoperative carbohydrate drink is used to improve patients' comfort and recovery, but evidence remains limited in diabetic patients. Herein we investigated the effects of preoperative carbohydrate loading with individualized supplemental insulin regimen in diabetic patients undergoing gastrointestinal surgery.
A total of 63 adult patients with type 2 diabetes mellitus undergoing major gastrointestinal surgery were randomized to receive either carbohydrate loading with individualized supplemental insulin (Carbohydrate group) or routine management (Control group). The primary outcome was time to first flatus after surgery. Among secondary outcomes, subjective feelings of thirsty, hunger and fatigue were assessed with the Visual Analogue Scale (scores range from 0 to 100, where 0 indicate no discomfort and 100 the most severe discomfort) before and after surgery. Adverse events were monitored until 24 h after surgery.
All patients were included in the intention-to-treat analysis. Time to first flatus did not differ between groups (median 41 h [IQR 18-69] in the Control group vs. 43 h [27-54] in the Carbohydrate group; hazard ratio 1.24 [95% CI 0.74-2.07]; P = 0.411). The VAS score of preoperative subject feeling of thirsty (median difference -33 [95% CI -50 to -15], P < 0.001), hunger (-25 [-40 to -10], P < 0.001), and fatigue (-5 [-30 to 0], P = 0.004), as well as postoperative subject feeling of thirsty (-50 [-60 to -30], P < 0.001), hunger (-20 [-40 to 0], P = 0.003), and fatigue (0 [-20 to 0], P = 0.020) were all significantly lower in the Carbohydrate group than in the Control group. Intraoperative hypotension (40.6% [13/32] vs. 16.1% [5/31], P = 0.031) and postoperative nausea and vomiting within 24 h (31.3% [10/32] vs. 9.7% [3/31], P = 0.034) occurred less in patients given carbohydrate drink.
In diabetic patients undergoing gastrointestinal surgery, preoperative carbohydrate loading with individualized supplemental insulin did not promote gastrointestinal recovery but improved perioperative well-being.
术前碳水化合物饮料可改善患者舒适度和恢复情况,但在糖尿病患者中的证据仍然有限。在此,我们研究了在接受胃肠手术的糖尿病患者中,使用个体化补充胰岛素方案的术前碳水化合物负荷的效果。
共有 63 名接受重大胃肠手术的 2 型糖尿病成年患者被随机分配接受碳水化合物负荷加个体化补充胰岛素(碳水化合物组)或常规治疗(对照组)。主要结局是术后首次排气时间。次要结局包括使用视觉模拟量表(评分范围为 0 至 100,其中 0 表示无不适,100 表示最严重不适)评估术前和术后口渴、饥饿和疲劳的主观感觉。监测不良事件直到术后 24 小时。
所有患者均纳入意向治疗分析。两组间首次排气时间无差异(对照组中位数 41 小时 [IQR 18-69] vs. 碳水化合物组 43 小时 [27-54];风险比 1.24 [95%CI 0.74-2.07];P=0.411)。术前口渴的 VAS 评分(中位数差值 -33 [95%CI -50 至 -15],P<0.001)、饥饿(-25 [-40 至 -10],P<0.001)和疲劳(-5 [-30 至 0],P=0.004),以及术后口渴(-50 [-60 至 -30],P<0.001)、饥饿(-20 [-40 至 0],P=0.003)和疲劳(0 [-20 至 0],P=0.020),碳水化合物组均明显低于对照组。术中低血压(40.6% [13/32] 与 16.1% [5/31],P=0.031)和术后 24 小时内恶心呕吐(31.3% [10/32] 与 9.7% [3/31],P=0.034)在接受碳水化合物饮料的患者中较少发生。
在接受胃肠手术的糖尿病患者中,术前碳水化合物负荷加个体化补充胰岛素并不能促进胃肠恢复,但可改善围手术期舒适度。